# A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tumors

> **NCT02103920** · — · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 1400 (estimated)

## Conditions studied

- Solid Tumor Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02103920
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2014-06
- **Final completion:** —
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103920, "A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02103920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*